Skip to main content
. 2016 Mar 24;2(1):7–11. doi: 10.5114/ceh.2016.58850

Table 2.

Regimens available and reimbursed in 2015 for treatment of chronic hepatitis C in Poland

Regimen Genotypes
1a 1b 2 3 4 5 6
OBV/PTV/r ± DSV ± RBV x x
OBV/PTV/r ± RBV x
ASV + DCV x
SOF/LDV x x
SOF + Peg-IFN + RBV x x x x x
SOF + RBV x x x x x

OBV – ombitasvir, PTV – paritaprevir, /r/ – ritonavir, DSV – dasabuvir, RBV – ribavirin, ASV – asunaprevir, DCV – daclatasvir, SOF – sofosbuvir, LDV – ledipasvir, Peg-IFN – pegylated interferon